⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ANVS News
Annovis Bio, Inc.
Annovis Bio Regains NYSE Listing Compliance
globenewswire.com
ANVS
Form 8-K
sec.gov
ANVS
Annovis Announces Pricing of $15.0 Million Public Offering of Common Stock and Accompanying Warrants
globenewswire.com
ANVS
Annovis Announces Launch of Proposed Public Offering of Common Stock and Accompanying Warrants
globenewswire.com
ANVS
Form 8-K
sec.gov
ANVS
Annovis Provides Corporate Updates and Reports First Quarter 2026 Financial Results
globenewswire.com
ANVS
Annovis CEO to Present on Multi-Protein Model of Alzheimer's Disease at Fierce Biotech Week 2026
globenewswire.com
ANVS
Annovis Publishes Phase 2/3 Alzheimer's Trial Results in Nature Portfolio
globenewswire.com
ANVS
Annovis Closes $10 Million Offering, Extending Cash Runway Through Phase 3 Alzheimer's Disease 6-Month NDA Submission
globenewswire.com
ANVS
Form 8-K
sec.gov
ANVS